Advantage Alpha Capital Partners’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-241,077
Closed -$6M 87
2025
Q3
$6M Buy
241,077
+69,720
+41% +$1.5M 1.81% 4
2025
Q2
$3.94M Buy
+171,357
New +$3.97M 1.06% 41
2025
Q1
Sell
-115,227
Closed -$2.25M 163
2024
Q4
$2.25M Buy
+115,227
New +$2.28M 0.53% 73
2024
Q2
Sell
-262,824
Closed -$5.15M 163
2024
Q1
$5.15M Buy
262,824
+85,728
+48% +$1.81M 0.97% 44
2023
Q4
$4.08M Buy
177,096
+22,879
+15% +$512K 0.77% 61
2023
Q3
$3.55M Buy
154,217
+10,828
+8% +$275K 0.75% 67
2023
Q2
$3.74M Buy
143,389
+817
+0.6% +$21.6K 0.75% 63
2023
Q1
$3.94M Buy
142,572
+79,871
+127% +$2.11M 0.82% 59
2022
Q4
$1.42M Sell
62,701
-42,936
-41% -$1.2M 0.3% 84
2022
Q3
$3.6M Sell
105,637
-164,676
-61% -$6.09M 0.66% 57
2022
Q2
$7.87M Buy
270,313
+42,745
+19% +$1.09M 1.36% 34
2022
Q1
$6.08M Buy
227,568
+54,269
+31% +$1.28M 0.91% 53
2021
Q4
$4.48M Buy
+173,299
New +$4.32M 0.64% 76

Other funds holding PRVA